
08/07/2025
UT Health Austin Pediatric Neurosciences at Dell Children's Medical Center now offers Elevidys, the first FDA-approved gene therapy for Duchenne muscular dystrophy (DMD) in ambulatory children aged 4 and older.
By combining world-class pediatric neurology, physical medicine, rehabilitation, and genetic counseling under one roof, families now have access to truly comprehensive care, close to home.
🖇️
UT Health Austin Pediatric Neurosciences at Dell Children's offers an innovative new treatment to patients under the age of two.